Literature DB >> 11182983

Cardiac dysfunction and mortality in HIV-infected children: The Prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group.

S E Lipshultz1, K A Easley, E J Orav, S Kaplan, T J Starc, J T Bricker, W W Lai, D S Moodie, G Sopko, S D Colan.   

Abstract

BACKGROUND: Left ventricular (LV) dysfunction is common in children infected with the human immunodeficiency virus (HIV), but its clinical importance is unclear. Our objective was to determine whether abnormalities of LV structure and function independently predict all-cause mortality in HIV-infected children. METHODS AND
RESULTS: Baseline echocardiograms were obtained on 193 children with vertically transmitted HIV infection (median age, 2.1 years). Children were followed up for a median of 5 years. Cox regression was used to identify measures of LV structure and function predictive of mortality after adjustment for other important demographic and baseline clinical risk factors. The time course of cardiac variables before mortality was also examined. The 5-year cumulative survival was 64%. Mortality was higher in children who, at baseline, had depressed LV fractional shortening (FS) or contractility; increased LV dimension, thickness, mass, or wall stress; or increased heart rate or blood pressure (P0.02 for each). Decreased LV FS (P<0.001) and increased wall thickness (P=0.004) were also predictive of increased mortality after adjustment for CD4 count (P<0.001), clinical center (P<0.001), and encephalopathy (P<0.001). FS showed abnormalities for up to 3 years before death, whereas wall thickness identified a population at risk only 18 to 24 months before death.
CONCLUSIONS: Depressed LV FS and increased wall thickness are risk factors for mortality in HIV-infected children independent of depressed CD4 cell count and neurological disease. FS may be useful as a long-term predictor and wall thickness as a short-term predictor of mortality.

Entities:  

Mesh:

Year:  2000        PMID: 11182983      PMCID: PMC4307402          DOI: 10.1161/01.cir.102.13.1542

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

1.  Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1987-04-24       Impact factor: 17.586

2.  Alterations in cardiac and pulmonary function in pediatric rapid human immunodeficiency virus type 1 disease progressors. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Study Group.

Authors:  W T Shearer; S E Lipshultz; K A Easley; K McIntosh; J Pitt; T C Quinn; M Kattan; J Goldfarb; E Cooper; Y Bryson; A Kovacs; J T Bricker; H Peavy; R B Mellins; N Heart; L B Institute
Journal:  Pediatrics       Date:  2000-01       Impact factor: 7.124

3.  Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group.

Authors:  S E Lipshultz; K A Easley; E J Orav; S Kaplan; T J Starc; J T Bricker; W W Lai; D S Moodie; K McIntosh; M D Schluchter; S D Colan
Journal:  Circulation       Date:  1998-04-07       Impact factor: 29.690

4.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

Authors:  R B Devereux; D R Alonso; E M Lutas; G J Gottlieb; E Campo; I Sachs; N Reichek
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

5.  Development of normalized curves for the international growth reference: historical and technical considerations.

Authors:  M J Dibley; J B Goldsby; N W Staehling; F L Trowbridge
Journal:  Am J Clin Nutr       Date:  1987-11       Impact factor: 7.045

6.  The pediatric pulmonary and cardiovascular complications of vertically transmitted human immunodeficiency virus (P2C2 HIV) infection study: design and methods. The P2C2 HIV Study Group.

Authors: 
Journal:  J Clin Epidemiol       Date:  1996-11       Impact factor: 6.437

7.  Cardiac complications in children with human immunodeficiency virus infection. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group, National Heart, Lung, and Blood Institute.

Authors:  T J Starc; S E Lipshultz; S Kaplan; K A Easley; J T Bricker; S D Colan; W W Lai; W M Gersony; G Sopko; D S Moodie; M D Schluchter
Journal:  Pediatrics       Date:  1999-08       Impact factor: 7.124

8.  Effect of intravenous immunoglobulin (IVIG) on CD4+ lymphocyte decline in HIV-infected children in a clinical trial of IVIG infection prophylaxis. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.

Authors:  L M Mofenson; J Bethel; J Moye; P Flyer; R Nugent
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-10

9.  Immunoglobulins and left ventricular structure and function in pediatric HIV infection.

Authors:  S E Lipshultz; E J Orav; S P Sanders; S D Colan
Journal:  Circulation       Date:  1995-10-15       Impact factor: 29.690

10.  Chest radiographic data acquisition and quality assurance in multicenter studies.

Authors:  R H Cleveland; M Schluchter; B P Wood; W E Berdon; M I Boechat; K A Easley; M Meziane; R B Mellins; K I Norton; E Singleton; L Trautwein
Journal:  Pediatr Radiol       Date:  1997-11
View more
  48 in total

1.  Absence of cardiac toxicity of zidovudine in infants.

Authors:  W Lewis
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

2.  Reliability of multicenter pediatric echocardiographic measurements of left ventricular structure and function: the prospective P(2)C(2) HIV study.

Authors:  S E Lipshultz; K A Easley; E J Orav; S Kaplan; T J Starc; J T Bricker; W W Lai; D S Moodie; G Sopko; M D Schluchter; S D Colan
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

Review 3.  Cardiovascular manifestations of HIV infection.

Authors:  G Barbaro
Journal:  J R Soc Med       Date:  2001-08       Impact factor: 5.344

Review 4.  HIV and cardiovascular medicine.

Authors:  B D Prendergast
Journal:  Heart       Date:  2003-07       Impact factor: 5.994

5.  Resolution of dilated cardiomyopathy in an adolescent with change of a failing highly active antiretroviral drug therapy.

Authors:  Twalib Olega Aliku; Sulaiman Lubega; Peter Lwabi
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

6.  Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).

Authors:  Steven E Lipshultz; William T Shearer; Bruce Thompson; Kenneth C Rich; Irene Cheng; E John Orav; Sulekha Kumar; Ricardo H Pignatelli; Louis I Bezold; Philip LaRussa; Thomas J Starc; Julie S Glickstein; Sharon O'Brien; Ellen R Cooper; James D Wilkinson; Tracie L Miller; Steven D Colan
Journal:  J Am Coll Cardiol       Date:  2011-01-04       Impact factor: 24.094

7.  Cardiac manifestations in HIV infected children.

Authors:  Pradeep Singh; Alok Hemal; Sheetal Agarwal; Dinesh Kumar
Journal:  Indian J Pediatr       Date:  2014-05-25       Impact factor: 1.967

8.  State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary.

Authors:  Steven K Grinspoon; Carl Grunfeld; Donald P Kotler; Judith S Currier; Jens D Lundgren; Michael P Dubé; Steven E Lipshultz; Priscilla Y Hsue; Kathleen Squires; Morris Schambelan; Peter W F Wilson; Kevin E Yarasheski; Colleen M Hadigan; James H Stein; Robert H Eckel
Journal:  Circulation       Date:  2008-06-19       Impact factor: 29.690

Review 9.  Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research.

Authors:  Joshua Remick; Vasiliki Georgiopoulou; Catherine Marti; Igho Ofotokun; Andreas Kalogeropoulos; William Lewis; Javed Butler
Journal:  Circulation       Date:  2014-04-29       Impact factor: 29.690

10.  Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study.

Authors:  Steven E Lipshultz; Kirk A Easley; E John Orav; Samuel Kaplan; Thomas J Starc; J Timothy Bricker; Wyman W Lai; Douglas S Moodie; George Sopko; Mark D Schluchter; Steven D Colan
Journal:  Lancet       Date:  2002-08-03       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.